Back to Search
Start Over
How long will chronic myeloid leukemia patients treated with imatinib mesylate live?
- Source :
- Leukemia (08876924); Apr2005, Vol. 19 Issue 4, p497-499, 3p
- Publication Year :
- 2005
-
Abstract
- Focuses on the survival of chronic myeloid leukemia (CML) patients treated with imatinib mesylate. Significance of the approval of imatinib mesylate for the treatment of Philadelphia chromosome-positive CML; Examination on the cytogenetic response of patients treated with the novel agent; Assessment on the efficacy of the new treatment approach compared with interferon.
Details
- Language :
- English
- ISSN :
- 08876924
- Volume :
- 19
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Leukemia (08876924)
- Publication Type :
- Academic Journal
- Accession number :
- 16892795
- Full Text :
- https://doi.org/10.1038/sj.leu.2403686